Genmab A/S ADR is now listed on the NASDAQ stock exchange.
8 reports, 2 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Genmab A/S ADR is now listed on the NASDAQ stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- LexinFintech ADR was listed on the Nasdaq exchange on August 1, 2026.
- Telix Pharmaceuticals Limited announced that it is utilizing the Nasdaq exchange for its ADR listing.
- Compass Pathways ADR trading on the Nasdaq stock exchange.
- ADMA Biologics, Inc. filed a lawsuit and was listed on the Nasdaq stock exchange.
- Evergy listed its shares on the stock exchange on August 4, 2026.